Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 4/20 | 0.36 |
| ▸ | METAP1 | P53582 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6233200 | 0.84 | ALOX15 (0.38) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| Hydrochloric Acid SCHEMBL11865499 | 0.83 | ALDH1A1 (0.35) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL110807 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL6304330 | 0.81 | METAP2 (0.45) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL12707509 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL11739657 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL112490 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL110806 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL12438531 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 | |
| SCHEMBL12655937 | 0.81 | ALOX15 (0.42) | ALDH1A1LMNAHSD17B10ALOX15CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1231886-A4 | TOPICAL SKIN COMPOSITION | ACCESS BUSINESS GROUP INT LLC (US) | 2005-10-12 | — | — | EP | claimed |
| CN-1424900-A | Topical skin composition | TONDAR COMMERCIAL GROUP INTERN (US) | 2003-06-18 | — | — | CN | claimed |
| US-20030095959-A1 | Topical skin composition | ACCESS BUSINESS GROUP INTERNATIONAL LLC. | 2003-05-22 | — | — | US | claimed |
| EP-1231886-A1 | TOPICAL SKIN COMPOSITION | Alticor Inc. (US) | 2002-08-21 | — | — | EP | claimed |
| WO-2001037788-A1 | TOPICAL SKIN COMPOSITION | ALTICOR INC. (US) | 2001-05-31 | — | — | WO | claimed |
| CN-102406607-B | Tiopronin liposome injection | HAINAN LINGKANG PHARMACEUTICAL | 2012-11-21 | — | — | CN | disclosed |
| CN-102406607-A | Tiopronin liposome injection | HAINAN LINGKANG PHARMACEUTICAL | 2012-04-11 | — | — | CN | disclosed |
| CN-101522266-A | Topical skin compositions, their preparation, and their use | ACCESS BUSINESS GROUP INT LLC (US) | 2009-09-02 | — | — | CN | disclosed |
| US-20080124409-A1 | Topical Skin Compositions, Their Preparation, and Their Use | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2008-05-29 | — | — | US | disclosed |
| US-20080081034-A1 | Topical Skin Compositions, Their Preparation, and Their Use | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2008-04-03 | — | — | US | disclosed |
| US-20080081082-A1 | Topical Skin Compositions, Their Preparation, and Their Use | ACCESS BUSINES GROUP INTERNATIONAL LLC | 2008-04-03 | — | — | US | disclosed |
| WO-2008016842-A1 | TOPICAL SKIN COMPOSITIONS, THEIR PREPARATION, AND THEIR USE | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008016838-A1 | TOPICAL SKIN COMPOSITIONS, THEIR PREPARATION AND THEIR USE | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2008-02-07 | — | — | WO | disclosed |
| US-20070003536-A1 | Topical skin compositions, their preparation, and their use | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2007-01-04 | — | — | US | disclosed |
| EP-1231886-A4 | TOPICAL SKIN COMPOSITION | ACCESS BUSINESS GROUP INT LLC (US) | 2005-10-12 | — | — | EP | disclosed |
| CN-1424900-A | Topical skin composition | TONDAR COMMERCIAL GROUP INTERN (US) | 2003-06-18 | — | — | CN | disclosed |
| US-20030095959-A1 | Topical skin composition | ACCESS BUSINESS GROUP INTERNATIONAL LLC. | 2003-05-22 | — | — | US | disclosed |
| EP-1231886-A1 | TOPICAL SKIN COMPOSITION | Alticor Inc. (US) | 2002-08-21 | — | — | EP | disclosed |
| WO-2001037788-A1 | TOPICAL SKIN COMPOSITION | ALTICOR INC. (US) | 2001-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081034-A1 | Topical Skin Compositions, Their Preparation, and Their Use | COL14A1, MMP8, MMP1 | ALDH1A1 1551/4885LMNA 200/4885HSD17B10 1453/4885 |
| US-20080124409-A1 | Topical Skin Compositions, Their Preparation, and Their Use | COL14A1, MMP8, MMP1 | ALDH1A1 1551/4885LMNA 200/4885HSD17B10 1453/4885 |
| US-20030095959-A1 | Topical skin composition | CUTA, S100A4, KRT18 | ALDH1A1 1227/4885LMNA 2296/4885HSD17B10 1033/4885 |
| US-20070003536-A1 | Topical skin compositions, their preparation, and their use | COL14A1, MMP8, MMP1 | ALDH1A1 1551/4885LMNA 200/4885HSD17B10 1453/4885 |
| US-20080081082-A1 | Topical Skin Compositions, Their Preparation, and Their Use | COL14A1, MMP8, MMP1 | ALDH1A1 1551/4885LMNA 200/4885HSD17B10 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.